GlassScriptPhysician profile
Emily Cline
NPI 1023125440
$11,662.49
in general payments reported to CMS, 2019-2025
32 companies · $510 in 2025
The $510 reported for 2025 was more than what 75% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,413 · 2020: $486 · 2021: $1,255 · 2022: $1,466 · 2023: $1,867 · 2024: $666 · 2025: $510.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,128 · Travel and Lodging: $816 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,128.24 |
| Travel and Lodging | $816.01 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $4,385.42 | 2019 | |
| Axonics, INC. | $3,058.43 | 2020-2024 | Axonics, Bulkamid |
| Boston Scientific Corporation | $1,136.47 | 2019-2025 | Axonics |
| Applied Medical Resources Corporation | $651.35 | 2022 | |
| Astellas Pharma US INC | $365.47 | 2022-2025 | Veozah |
| Abbvie INC. | $311.68 | 2019-2025 | Lo Loestrin Fe, Orilissa |
| Bayer Healthcare Pharmaceuticals INC. | $249.95 | 2020-2025 | |
| Coopersurgical, INC. | $191.80 | 2019-2025 | Endosee, Paragard T 380a, Paragard T 380a |
| Mayne Pharma Commercial LLC | $186.32 | 2022-2025 | |
| Medtronic, INC. | $152.19 | 2021-2025 | Interstim, Altaviva |
| Exeltis, USA INC. | $134.91 | 2021-2025 | Slynd |
| Hologic Sales and Service, LLC | $121.63 | 2019-2024 | Novasure |
| Therapeuticsmd, INC. | $114.72 | 2019-2022 | |
| Pfizer INC. | $99.85 | 2022-2024 | |
| Coloplast Corp | $97.90 | 2021-2024 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $48.47 | 2022-2025 | Evenity, Prolia |
| Sumitomo Pharma America, INC. | $41.73 | 2024 | Gemtesa, Myfembree |
| Millicent US INC | $41.62 | 2024-2025 | Intrarosa |
| Ethicon US, LLC | $36.56 | 2023 | Echelon Circular, Echelon Flex, Endopath |
| Vertical Pharmaceuticals, LLC | $27.59 | 2019-2020 | |
| Caldera Medical, INC | $24.74 | 2022 | |
| Roche Diagnostics Corporation | $24.56 | 2019 | |
| Agiliti Surgical, INC. | $24.40 | 2021 | |
| Exact Sciences Corporation | $21.67 | 2024 | Cologuard Collection Kit |
| Innovation Technologies INC | $20.66 | 2024 | Irrisept |
| Grt US Holding, INC. | $18.57 | 2022 | |
| Amag Pharmaceuticals, INC. | $15.04 | 2019 | |
| Medtronic USA, INC. | $13.18 | 2020 | |
| Mallinckrodt Enterprises LLC | $12.35 | 2019 | |
| Minerva Surgical, INC | $12.20 | 2022 | |
| Mission Pharmacal Company | $11.41 | 2019 | |
| Meditrina | $9.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Cline listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.